ArticleInvestigational new drugs2019

Phase Ib study of pevonedistat, a NEDD8-activating enzyme inhibitor, in combination with docetaxel, carboplatin and paclitaxel, or gemcitabine, in patients with advanced solid tumors.

A Craig Lockhart et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.